切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2018, Vol. 08 ›› Issue (01) : 49 -52. doi: 10.3877/cma.j.issn.2095-1221.2018.01.009

所属专题: 文献

综述

多能干细胞诱导分化为肾脏类器官的分子机制及应用前景分析
张登禄1, 杜枭航2, 孔峰2, 赵升田3,()   
  1. 1. 250011 济南,山东中医药大学附属医院实验中心;250033 济南,山东省肾脏再生医学省级重点实验室
    2. 250033 济南,山东省肾脏再生医学省级重点实验室
    3. 250011 济南,山东中医药大学附属医院泌尿外科;250033 济南,山东省肾脏再生医学省级重点实验室
  • 收稿日期:2016-09-30 出版日期:2018-02-01
  • 通信作者: 赵升田

Molecular mechanism and application of kidney organoids from pluripotent cells

Denglu Zhang1, Xiaohang Du2, Feng Kong2, Shengtian Zhao3,()   

  1. 1. Central Laboratory, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China; Key Laboratory of Kidney Regeneration of Shandong Province, Jinan 250033, China
    2. Key Laboratory of Kidney Regeneration of Shandong Province, Jinan 250033, China
    3. Department of Urology, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China; Key Laboratory of Kidney Regeneration of Shandong Province, Jinan 250033, China
  • Received:2016-09-30 Published:2018-02-01
  • Corresponding author: Shengtian Zhao
  • About author:
    Corresponding author: Zhao Shengtian, Email:
引用本文:

张登禄, 杜枭航, 孔峰, 赵升田. 多能干细胞诱导分化为肾脏类器官的分子机制及应用前景分析[J/OL]. 中华细胞与干细胞杂志(电子版), 2018, 08(01): 49-52.

Denglu Zhang, Xiaohang Du, Feng Kong, Shengtian Zhao. Molecular mechanism and application of kidney organoids from pluripotent cells[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2018, 08(01): 49-52.

干细胞具有自我更新和多向分化潜能,在再生医学领域发挥着越来越大的作用。肾脏类器官是一种由干细胞分化而来具有一定肾脏功能的组织结构,可用于肾脏疾病的细胞修复治疗,也可以模拟肾脏发育和疾病发生及用于筛选改善肾功能的药物。肾脏类器官的体外培育成为了当前研究热点,其体外培育可分为几个阶段:干细胞-原始体节中胚层-中间中胚层-输尿管芽(后肾间质)-集合管(肾单位)。本文重点介绍了目前两种较为成熟的肾脏类器官体外诱导方法,并对肾脏类器官的应用前景进行了综述。

Stem cells with the potential of self-renewal and multilineage differentiation play an increasingly important role in the field of regenerative medicine. Kidney organoids, a kind of tissue structure with certain renal function that derived from stem cells, could be used for cell repair therapy of renal diseases, or for imitating kidney development and disease occurrence so as to screen the drugs which could improve renal function. The culture of kidney organoids in vitro becomes a research hotspot at present. The in vitro culture could be divided into several stages as follows: stem cells-primordial somatic mesoderm-intermediate mesoderm-ureteric bud/metanephric mesenchyme-collecting tube/nephron. Two kinds of more mature in vitro induction methods of kidney organoids at present are focused on and the application prospect of kidney organoids are reviewed.

图1 肾脏类器官诱导过程中主要信号通路
1
Radhakrishnan J, Remuzzi G, Saran R, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts[J]. Kidney Int, 2014, 86(2):246-250.
2
Little MH, Mcmahon AP. Mammalian kidney development: principles, progress, and projections[J]. Cold Spring Harb Perspect Biol, 2012, 4(5).
3
Kobayashi A, Valerius MT, Mugford JW, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development[J]. Cell Stem Cell, 2008, 3(2):169-181.
4
Carroll TJ, Park JS, Hayashi S, et al. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system[J]. Dev Cell, 2005, 9(2):283-292.
5
Takasato M, Er PX, Chiu HS, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis[J]. Nature, 2015, 526(7574):564-568.
6
Morizane R, Lam AQ, Freedman BS, et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury[J]. Nat Biotechnol, 2015, 33(11):1193-1200.
7
Taguchi A, Kaku Y, Ohmori T, et al. Redefining the in vivo origin of metanephric nephron progenitors enables Generation of complex kidney structures from pluripotent stem cells[J]. Cell Stem Cell, 2014, 14(1):53-67.
8
Gadue P, Huber TL, Paddison PJ, et al. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells[J]. Proc Natl Acad Sci U S A, 2006, 103(45):16806-16811.
9
Soares ML, Haraguchi S, Torres-Padilla ME, et al. Functional studies of signaling pathways in peri-implantation development of the mouse embryo by RNAi[J]. BMC Dev Biol, 2005, 5:28.
10
Sumi T, Tsuneyoshi N, Nakatsuji N, et al. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling[J]. Development, 2008, 135(17):2969-2979.
11
Mae S, Shono A, Shiota F, et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells[J]. Nat Commun, 2013, 4:1367.
12
James RG, Kamei CN, Wang Q, et al. Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells[J]. Development, 2006, 133(15):2995-3004.
13
Tsang TE, Shawlot W, Kinder SJ, et al. Lim1 activity is required for intermediate mesoderm differentiation in the mouse embryo[J]. Dev Biol, 2000, 223(1):77-90.
14
Crossley PH, Martin GR. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo[J]. Development, 1995, 121(2):439-451.
15
Colvin JS, Feldman B, Nadeau JH, et al. Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene[J]. Dev Dyn, 1999, 216(1):72-88.
16
Takasato M, Er PX, Becroft M, et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney[J]. Nat Cell Biol, 2014, 16(1):118-126.
17
Rosselot C, Spraggon L, Chia I, et al. Non-cell-autonomous retinoid signaling is crucial for renal development[J]. Development, 2010, 137(2):283-292.
18
Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia[J]. J Am Soc Nephrol, 2005, 16(12):3527-3534.
19
Barak H, Huh SH, Chen S, et al. FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man[J]. Dev Cell, 2012, 22(6):1191-1207.
20
Tiong HY, Huang P, Xiong S, et al. Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models[J]. Mol Pharm, 2014, 11(7):1933-1948.
21
Li Y, Kandasamy K, Chuah JK, et al. Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells[J]. Mol Pharm, 2014, 11(7):1982-1990.
22
Bartfeld S, Bayram T, van de Wetering M, et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection[J]. Gastroenterology, 2015, 148(1): 126-136.e6.
[1] 雷子威, 凌萍, 沈纵, 魏晨如, 朱邦晖, 伍国胜, 孙瑜. 类器官肺损伤疾病模型构建及应用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 531-535.
[2] 杨柳, 陈佳, 孙雅娟, 陈娇, 谭明超, 龚明福. 抗中性粒细胞胞浆抗体相关性血管炎的胸部CT 及临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 744-749.
[3] 周学锋, 董哲毅, 冯哲, 蔡广研, 陈香美. 糖尿病肾脏疾病中西医结合诊疗指南计划书[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 301-305.
[4] 程柏凯, 杨光. 高胰岛素-正葡萄糖钳夹技术评估慢性肾脏病患者胰岛素抵抗的研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 334-339.
[5] 王小龙, 吴杰, 冯哲, 文浩, 段姝伟, 梁爽, 蔡广研. 心内科病房急性肾损伤且行肾脏替代治疗患者短期预后不良的危险因素分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 241-248.
[6] 冯熔熔, 苏晓乐, 王利华. 慢性肾脏病患者并发心血管疾病相关生物标志物研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 273-278.
[7] 郭俊楠, 林惠, 任艺林, 乔晞. 氨基酸代谢异常在急性肾损伤向慢性肾脏病转变中的作用研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 283-287.
[8] 崔文鹏. 腹膜透析在老年终末期肾脏疾病患者中的应用[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 300-300.
[9] 涂晓文. 糖尿病肾脏病的靶点药物研发进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 240-240.
[10] 刘俊, 陈客宏. 终末期肾脏病患者运动干预的作用研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 219-225.
[11] 邱英鹏, 李欣雨, 邱海波, 刘松桥, 张凌, 于湘友, 秦秉玉, 蒲莹莹, 赵佳钰, 刘永军, 肖月, 杨毅. 连续性肾脏替代治疗质量控制指标体系的建立及验证[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 351-357.
[12] 向阳, 史黎炜, 肖月, 邱海波, 杨毅, 刘松桥, 邱英鹏, 张莹. 连续性肾脏替代治疗在我国五地区重症医学科的效率分析[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 358-363.
[13] 张津, 李欣达, 徐如祥. 神经类器官在大脑常见疾病治疗中的应用及在脊髓损伤修复中的应用前景[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 257-263.
[14] 奚培培, 周加军. 慢性肾脏病患者肌少症机制和诊治的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 491-495.
[15] 孙双权, 孙玮玮, 王勇, 方道成, 温晖. 肾脏混合性上皮和间质肿瘤一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 512-515.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?